Article thumbnail

Evaluating human papillomavirus vaccination programs in Canada: should provincial healthcare pay for voluntary adult vaccination?

By Marco Llamazares and Robert J Smith?
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2373297
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2007). A: Prophylactic HPV vaccines.
  2. (2007). Boily MC: The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada. Vaccine
  3. (2007). Colzani E: Age at first intercourse and HPV immunization. J Prev Med Hyg
  4. (2006). Epidemiol Rev
  5. (2007). HPV Vaccine Adolescent Study Investigators Network: Immunization of early adolescent females with human papillomavirus type 16 and 18 L1 virus-like particle containing AS04 adjuvant.
  6. (1988). Human papillomavirus [http://www.emedi cine.com/med/topic1037.htm] 2. Koutsky LA, Galloway DA, Holmes KK: Epidemiology of genital human papillomavirus infection. Epidemiol Rev
  7. (2007). Human papillomavirus and cervical cancer. Lancet
  8. (2007). Impact of vaccination against oncogenic human papillomavirus on the incidence and mortality of cervical cancer in Germany. Med
  9. (2007). Insinga RP: Model for Assessing Human Papillomavirus Vaccination Strategies. Emerging Infectious Diseases
  10. (2007). Izetbegović S: Primary prevention of cervical carcinoma. Med Arh
  11. (2007). JP: Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sexspecific pattern of vaccination in Finland.
  12. (2007). Meijer CJ, Kimman TG: Assessing the introduction of universal human papillomavirus vaccination for preadolescent girls in The Netherlands. Vaccine
  13. (1999). Meijer CJ, Muñoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol
  14. (2007). Ontario Ministry of Health and Long-Term Care, Human Papilloma Virus Immunization Program Backgrounder [http://www.health.gov.on.ca/english/media/news_releases/archives/ nr_07/aug/bg_20070802.html] 21. Marshall
  15. (2007). Papanicolaou smears and cervical inflmmatory cytokine responses.
  16. (2007). Progression and regression of incident cervical
  17. (2006). Prophylactic human papillomavirus vaccines.
  18. (2006). Public Health Agency of Canada, Human Papillomavirus (HPV) Prevention and HPV Vaccine: Questions and Answers [http://www.phac-aspc.gc.ca/std-mts/hpv-vph/hpv-vphvaccine_e.html] 12. Harper
  19. (1998). RD: Natural History of Cervicovaginal Papillomavirus Infection in Young Women.
  20. (2006). SJ: Modelling the impact of HPV vaccines on cervical cancer and screening programmes. Vaccine
  21. (2002). SM: Could widespread use of combination antiretroviral therapy eradicate HIV epidemics? Lancet Infect Dis
  22. (2002). The theoretical population level impact of a prophylactic human papilloma virus vaccine. Epidemiology
  23. (2007). Tricco AC: A dynamic model for assessing universal Hepatitis A vaccination in Canada. Vaccine
  24. (2007). Vonau B: Human papilloma virus vaccine – more than a vaccine. Current Opinion